FDA 483 - Biomay AG - July 27, 2023

An FDA inspection of Biomay AG in Vienna, Austria, revealed significant deficiencies in contamination control and equipment qualification. Observations included equipment not in good repair and improper storage of cleaning materials, indicating a failure to follow established procedures. Additionally, the firm failed to perform an adequate air visualization study to qualify critical manufacturing equipment.